Want to create an interactive transcript for this episode?
Podcast: American Medicine Today - Radio
Episode: DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG “LAQEMBI” - 8 19 23
Description: THE FDA RECENTLY GAVE FULL APPROVAL TO A NEW DRUG CALLED LEQEMBI, WHICH IS BEING HAILED AS “A NEW ERA IN ALZHEIMER’S TREATMENT”. WE SPEAK WITH NIKHIL PALEKAR, MD - DIRECTOR OF THE STONY BROOK CENTER OF EXCELLENCE FOR ALZHEIMER’S DISEASE AND DIRECTOR OF THE STONY BROOK ALZHEIMER’S DISEASE CLINICAL TRIALS PROGRAM TO DISCUSS THE DETAILS.